(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RENAGADE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RENAGADE

ST13

US500000090545046

Class

1

Filing

90545046

Registration

6969702

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

09/13/2024

Trademark type

Word

Nice classes

1

Filing date

02/24/2021

Registration date

01/31/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/31/2023

Last transaction

09/13/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/16/2022

First use in commerce

11/16/2022

Drawing code

4

Owner type

16

Owner location

Watertown, MA

Examiner

PETTICAN, NATHANIEL

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Renagade Therapeutics LLC
Renagade Therapeutics LLC

Representatives

Jonathan M. Gelchinsky Pierce Atwood LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemical preparations for scientific purposes; Nucleic acid for laboratory use; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseasescancersneurological disorderscardiovascular disordersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders and reproductive disorders; Biochemicals for in vitro and in vivo scientific use; Biochemicalspolynucleotides for in vitro and in vivo scientific and research purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Reagents for scientific or medical research use

Publications

History of USPTO decisions and trademark events.

49 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/13/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/13/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/13/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/13/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/13/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/13/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/31/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/31/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/24/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/23/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/22/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/13/2022

GNRT

NON-FINAL ACTION E-MAILED

12/13/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

12/13/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/12/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/05/2022

IUAF

USE AMENDMENT FILED

11/16/2022

EISU

TEAS STATEMENT OF USE RECEIVED

11/16/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/13/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/13/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/13/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/13/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/13/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/10/2022

PUBO

PUBLISHED FOR OPPOSITION

05/10/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

04/01/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/01/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

04/01/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/31/2022

ALIE

ASSIGNED TO LIE

03/31/2022

NREV

NOTICE OF REVIVAL - E-MAILED

03/30/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/29/2022

PETG

PETITION TO REVIVE-GRANTED

03/29/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

03/29/2022

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

03/29/2022

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

03/29/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/15/2021

GNRT

NON-FINAL ACTION E-MAILED

09/15/2021

CNRT

NON-FINAL ACTION WRITTEN

09/15/2021

DOCK

ASSIGNED TO EXAMINER

09/15/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/26/2021

NWAP

NEW APPLICATION ENTERED

02/27/2021

Continuous trademark protection

Get notified about every new filing that threatens RENAGADE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.